The United States' insufficient supply of H1N1 vaccines to inoculate our population demonstrates how poorly prepared we are to confront a pandemic.

AEI's Scott Gottlieb argues that the focus of legislation should not be on creating employment benefits specifically targeted to H1N1, but instead on ways to mitigate risks in future pandemics by providing Americans with early vaccinations.

U.S. regulations are too cautious. Europe has adopted a more sensible approach.

The United States can avoid national security threats by being better prepared for pandemic flu.

Ernst R. Berndt and Anjli C. Warner discuss their new book, U.S. Markets for Vaccines: Characteristics, Case Studies, and Controversies.

A little fear goes a long way in fighting a pandemic.

More public education would help stem the problem of fake pharmaceuticals--restricting Internet trade would not.

We must make a concerted effort today to increase our capacity for timely development of safe, effective and innovative flu vaccines.